Q: It’s often convenient to pass along a list of resources to patients, but we’ve found that this may not be the best approach when working with patients battling substance use disorders. What are your suggestions for providing help to these patients?
Q: We have patients being admitted for novel coronavirus (COVID-19) and most of them have a laundry list of various manifestations and complications. Do all manifestations and complications need to be reported in ICD-10-CM?
Q: If a person has a history of substance abuse, but at the time of admission appears to be of sound mind, is that patient’s personal representative still entitled to receive information about the patient’s treatment and status?
Q: As utilization review case managers, we are often tasked with assessing our hospital's risk for novel coronavirus (COVID-19) denials. What are the most important measures we should be examining?
Q: Many organizations have outsourced their PHI disposal for years. With coronavirus limiting the number of people coming in and out of medical facilities, what are your suggestions for organizations that now have to take care of PHI disposal themselves? What are the most important things to remember when handling this process?
Q: Would it be appropriate to use family psychotherapy CPT codes 90846-90849 to report therapy for the benefit one person that involves input from family members?
Q: If researchers want to obtain PHI for a person who died of COVID-19, what is the protocol for releasing that information? What are the HIPAA protections?
